Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thrombocythemia, Essential × Early Intervention, Educational × 30 days × Clear all

Sponsor

Conditions

Skin Carcinoma 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Pyloric Stenosis, Hypertrophic 1 Papillomavirus Infections 1 Pain 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1 Chemotherapy-Induced Peripheral Neuropathy 1

Interventions

ruxolitinib 3 venetoclax 1 veliparib 1 pevonedistat 1 iadademstat 1 fedratinib 1 decitabine and cedazuridine drug combination 1 bomedemstat 1 Topotecan 1 Specimen Handling 1 Injections 1 INCB057643 1 Decitabine 1 Carboplatin 1 Biopsy 1 Azacitidine 1 Acetylcysteine 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡